This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending d…

Type 1 Diabetes MellitusT1DT1DM+7 more

~Estimated

~$10 – $8,750

COUR Pharmaceutical Development Company, Inc.NCT06783309

Observational

Effectiveness of Artificial-Intelligence (AI) Bolus Priming Added to an Existing Fully Automated Control Algorithm (AIDANET)

Bolus Priming (BP) based on Artificial Intelligence (AI) learning of meal patterns, added to our established Automated insulin delivery as Adaptive Network (AI…

Type 1 Diabetes Mellitis

~Estimated

~$10 – $7,500

Sue BrownNCT07517770